{
    "2021-07-06": [
        [
            {
                "time": "2023-10-10",
                "original_text": "沃森生物：公司新冠疫苗临床试验的各项工作在正常推进中",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新冠疫苗",
                        "临床试验",
                        "正常推进"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "沃森生物：公司新冠mRNA疫苗采用的是mRNA技术",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA疫苗",
                        "mRNA技术"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "基因技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "中银国际：沃森生物(300142.SZ)致力于打造中国第一款国产mRNA疫苗，首予“增持”评级",
                "features": {
                    "keywords": [
                        "中银国际",
                        "沃森生物",
                        "mRNA疫苗",
                        "国产",
                        "增持评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "资金流向分析",
                "features": {
                    "keywords": [
                        "资金流向",
                        "分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}